ASH 2010 Conference Coverage
An evaluation of this mobile health app found easy to use for diverse, low-income women.
Patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer.
52% of those ages 45 to 75 years use aspirin, and another 21% had used it at some point in the past.
Cardiorespiratory fitness is associated with a decreased risk of metabolic syndrome among smokers.
[Translational Lung Cancer Research] In this article, the authors examine the role of adjuvant chemotherapy in the treatment of resected non-small cell lung cancer.
A higher fitness level leads to decreased risk of lung and colorectal cancer for men.
California and New York fully expanded Medicaid coverage under ACA, but Texas and Florida did not.
Truly shared decision-making is possible only when the patient understands everything the treatment options entail, and the doctor understands the patient's personal situation and desires.
A recent study examined why individuals do not always follow through with colorectal cancer screening.
After prostate cancer diagnosis, at least five hours of non-vigorous activity or 3 hours of walking is beneficial.
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Muscle-building supplements may be associated with testicular cancer
- Promising drug target identified in medulloblastoma
- Physical activity associated with less chemo-induced peripheral neuropathy
- mHealth app assesses breast cancer risk and aids prevention
- Socioeconomic factors increase mortality after lung cancer surgery
- Half of older U.S. adults take aspirin as preventive medicine
- Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
- Adjuvant chemotherapy in non-small cell lung cancer: State-of-the-art
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|